Biopharma Investment and Management

Primary Industry

• Industry
  Business Consulting and Services
• Size
  2-10 employees
• Company Type
  Privately Held

Biopharma Investment & Management (BIM) is a boutique management consultancy firm and immune-focused CRO, bridging science and business. Led by Dr. Lior Carmon, a biotech entrepreneur with extensive experience in translational medicine, immunology, and vaccinology, BIM offers in-depth expertise from concept to clinical trials. Dr. Carmon, with a PhD from Weizmann Institute, has contributed significantly to the field.

BIM’s team, with its deep scientific expertise and keen industry insights, crafts bespoke competitive strategies that align with each client’s unique needs. We support CEOs and business development leaders at the strategic level and collaborate with R&D to navigate everyday technological hurdles, boosting organizational performance. Our experience spans across diverse client sizes and types, ensuring tailored solutions for every partner.

Our Services include:
► Technical and business asset valuation for angel investors, VCs, and biopharma companies.
► Immunology-focused CRO providing tailored R&D solutions with hands-on project management.
► Asset scouting for pharma clients based on specific wish lists.
► Supporting founders, investors, and TTOs in shaping and accelerating new biotech ventures through strategic and operational execution.

Categories

• Consultancy Services

Regions

• Israel

Location